Editorial: Multiple Myeloma Immunotherapies
Curr Cancer Drug Targets
.
2017;17(9):768.
doi: 10.2174/156800961709171005160041.
Author
Klaus Podar
1
Affiliation
1
Department of Medical Oncology National Center for Tumor Diseases (NCT) University of Heidelberg. Germany.
PMID:
29117857
DOI:
10.2174/156800961709171005160041
No abstract available
Publication types
Editorial
MeSH terms
Antibodies, Monoclonal / therapeutic use*
Humans
Immune System / drug effects*
Immunotherapy*
Molecular Targeted Therapy*
Multiple Myeloma / immunology
Multiple Myeloma / therapy*
Substances
Antibodies, Monoclonal